Biotechnology
Everest Medicines to Announce 2026 Interim Results and Host Online Investor Call on August 19, 2026
SHANGHAI, Aug. 5, 2026 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization of innovative therapeutics, today announced that it will report its interim result...
2026-08-05 17:37
2610
Sisram Medical to Announce 2026 Interim Results on Wednesday, August 19, 2026
Earnings Conference Call to be Held on August 20, 2026 HONG KONG, Aug. 5, 2026 /PRNewswire/ -- Sisram Medical Ltd (the "Company" or " Sisram", 1696.HK), a global wellness group offering Energy-Based Devices ("EBD"), injectables, and other complementary solutions, today announced that it will repo...
2026-08-05 17:19
2291
NueCell Bio Announces its Launch as a New Translational Partner for Cell Therapies with Unique Expertise to Accelerate Treatments from Discovery into GMP Manufacturing
SAN DIEGO, Aug. 5, 2026 /PRNewswire/ -- NueCell Bio, a newly established cell therapy science and development services company that utilizes proprietary modular translational development solutions focused on advancing modern cell therapies from scientific discovery through clinical readiness, tod...
2026-08-05 15:00
2134
SOPHiA GENETICS Enters Collaboration to Develop Companion Diagnostics for Precision Oncology Therapies
BOSTON and ROLLE, Switzerland, Aug. 4, 2026 /PRNewswire/ -- SOPHiA GENETICS
2026-08-04 18:15
2607
MGI Tech and NCSTAR Sign Memorandum of Understanding to Explore Bringing Multi-Omics Infrastructure under DCSP framework to Queensland's Spatial Biology Research
Collaboration, coordinated through NCSTAR at QIMR Berghofer, gives Queensland researchers a pathway to trial and validate MGI's integrated DCSP framework — spanning DNA genomics, cell omics, spatial omics and proteomics — locally, fast-tracking their translation into real-world research and futur...
2026-08-04 17:50
2471
Sisram Medical Powers Up China EBD Growth Engine with Flagship "黑金牛奶光" Launch
Driving Innovation and Proactive Empowerment to Unlock Localized Growth in China HONG KONG, Aug. 4, 2026 /PRNewswire/ -- Sisram Medical Ltd (the "Company" or "Sisram", 1696.HK), a global wellness group offering Energy-Based Devices ("EBD"), injectables, and other complementary solutions, today un...
2026-08-04 17:37
4757
Ainex's ENAD Chosen for Singapore's National University Hospital After Global Competition
* ENAD, Korea's First and Only AI-Assisted Solution Approved for Both Upper and Lower GI Endoscopy * ENAD Secures Singapore Hospital Adoption in Competition with Medtronic, Olympus, and Fujifilm * Rapid Market Breakthrough Follows Singapore HSA Approval; Joint Research to Drive Further AI P...
2026-08-04 08:00
3902
Gene Solutions Advances Precision Oncology Education in Malaysia with the ''Beyond Actionable'' Academy
At the Precision Oncology Academy 2026, leading international experts explored how insights from tumour DNA and RNA can reveal treatment opportunities, explain drug resistance, and translate into more confident treatment decisions to improve cancer care. KUALA LUMPUR, Malaysia, Aug. 4, 2026 /PRN...
2026-08-04 06:00
15639
Enzene Launches NeX™, a Comprehensive Suite of Solutionsto Enable Cost-Efficient, High-Yielding Local Biomanufacturing
PUNE, India, Aug. 4, 2026 /PRNewswire/ -- Enzene, a leading global continuously innovative development and manufacturing organization (CIDMO™), today announced the launch of NeX™, a transformative end-to-end partnership model that enables governments, institutions, and biopharma organizations to ...
2026-08-04 02:25
4473
KPJ Healthcare Launches First Orthopaedic and Rheumatology Centre of Excellence Under the KPJ Health System
BUKIT MERTAJAM, Malaysia, Aug. 4, 2026 /PRNewswire/ -- KPJ Healthcare Berhad ("KPJ Healthcare" or "the Group") today launched its first Orthopaedic and Rheumatology Centre of Excellence ("CoE") at KPJ Penang Specialist Hospital ("KPJ Penang"), marking the third CoE under the KPJ Health System ("K...
2026-08-04 00:06
4543
Ascletis Announces Initiation of Global Phase III for Oral Small Molecule GLP-1, ASC30 and Positive Preclinical Data for Its First-in-Class Oral Small Molecule GLP-1/GIP/Amylin Fixed-Dose Combination
-Initiated global Phase III program for oral small molecule GLP-1, ASC30, which will enroll approximately 4,600 participants with obesity or overweight across two pivotal trials in the U.S., Europe, and Canada. -Positive preclinical data in non-human primates announced for first-in-class once-da...
2026-08-03 18:55
4010
CLASSYS Appoints Former Samsung Electronics Executive Vice President Jun-oh Yoon as CEO to Lead Its Next Stage of Global Growth
* Former Samsung Group and Samsung Electronics executive who led corporate growth strategy and major global M&A initiatives across the Corporate Strategy Office and DX Division * Brings extensive global leadership experience in business strategy, operations, and value creation across robotics...
2026-07-31 23:12
13150
Telix H1 2026 Results: Investor Webcast Notification
MELBOURNE, Australia and INDIANAPOLIS, July 31, 2026 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today advises that it will release its financial results for the half-year ended June 30, 2026 on Thursday August 20, 2026. An investor webcast and conference call ...
2026-07-31 06:41
3401
Continuity Biosciences Appoints Vicky Papoutsis to Board of Directors
Business development and corporate strategy executive joins Board as Company advances its clinical programs and partnering activity BRADENTON, Fla., July 30, 2026 /PRNewswire/ -- Continuity Biosciences today announced the appointment of Vicky Papoutsis to its Board of Directors. Vicky brings mor...
2026-07-30 20:00
1791
NMPA Accepts New Indication Application for Sacituzumab Tirumotecan (sac-TMT) as First-Line Treatment for Advanced TNBC
CHENGDU, China, July 30, 2026 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech" or the "Company", 6990.HK) announced that a new indication application of its trophoblast cell-surface antigen 2 (TROP2)-directed antibody drug conjugate (ADC) sacituzumab tirumotecan...
2026-07-30 17:19
2821
Propel Health Australia Highlights Emerging Research into Fulvic Acid and Microplastics
BRISBANE, Australia, July 30, 2026 /PRNewswire/ -- Propel Health is
highlighting new laboratory research published in Science of the Total
Environment showing that fulvic acid can interact directly with microplastic
particles under controlled conditions.
2026-07-30 08:01
1936
Sorona® and WGSN Announce Top Bio-Based Material Trends of 2027
Bio-based materials emerge as a leading trend shaping the future of fashion
across athleisure and luxury ready-to-wear apparel
NEWARK, Del., July 29, 2026 /PRNewswire/ -- Sorona
2026-07-29 10:13
2081
AbbVie Announces Availability of ELAHERE® (mirvetuximab soravtansine) in Singapore for the Treatment of Platinum-Resistant Ovarian Cancer
* ELAHERE is the first and only antibody-drug conjugate (ADC) therapy approved specifically for patients with folate receptor alpha (FRα) positive, platinum-resistant high grade serous epithelial ovarian cancer, fallopian tube or primary peritoneal cancer, who have received one to three prior s...
2026-07-29 10:00
2800
Ozelle Launches O-Cyte 1 at ADLM 2026, Marking a New Step in AI-Powered Hematology
The global launch brings image-based morphology intelligence into routine
hematology workflows through AI × CBM technology.
FRANKFURT, Germany and ANAHEIM, Calif., July 29, 2026 /PRNewswire/ -- Ozelle
2026-07-29 05:00
2038
LabAsia Returns to Borneo Amid Rising Demand for Laboratory Technologies
East Malaysia hosts Southeast Asia's leading laboratory exhibition as investment in research, healthcare and advanced manufacturing continues to grow. KUCHING, Malaysia, July 28, 2026 /PRNewswire/ -- LabAsia Borneo Edition 2026 officially opened today at the Borneo Convention Centre Kuching (BCCK...
2026-07-28 21:20
2721
Week's Top Stories
Most Reposted
Visa returns as title sponsor for 2026 MAMA AWARDS; Visa Presale registration begins 13 October
[Picked up by 310 media titles]
2026-10-13 10:00
Agoda Partners with Marina Bay Sands on Bespoke Flagship Store for Experience-Led Travel
[Picked up by 277 media titles]
2026-10-08 09:50
New Asia Forum Targets US$30 Billion in Investment into the New Asia at Its Inaugural Edition in Bali
[Picked up by 275 media titles]
2026-10-09 13:21DayOne Upsizes Malaysia Financing to US$7.2 Billion; Total Billings Surpass 1GW and Bookings Reach 2.3GW
[Picked up by 269 media titles]
2026-10-14 18:01Ampotech and Buskowitz Energy Collaborate to Deliver Integrated Energy Solutions Combining Energy Efficiency, Solar and Battery Storage
[Picked up by 263 media titles]
2026-10-14 09:30
Most Read
Nuix Neo Generative AI Framework
2026-10-08 08:02
14818
LEIFRAS Co., Ltd. Reports First Half of Fiscal Year 2026 Financial Results
2026-10-08 09:50
12807
XPENG G9L Completes First Production Trial in Europe
2026-10-08 07:33
12377
